Abstract
This special number is dedicated to the Editorial Advisory Board Members of CNS & Neurological Disorders-Drug Targets.
CNS & Neurological Disorders - Drug Targets
Title:Dedication:
Volume: 14 Issue: 4
Author(s):
Affiliation:
Abstract: This special number is dedicated to the Editorial Advisory Board Members of CNS & Neurological Disorders-Drug Targets.
Export Options
About this article
Cite this article as:
, Dedication:, CNS & Neurological Disorders - Drug Targets 2015; 14 (4) . https://dx.doi.org/10.2174/187152731404150508103408
DOI https://dx.doi.org/10.2174/187152731404150508103408 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Difficulty with Uncertainty: How It Presents in Eating Disorders and What We Can Do About it
Adolescent Psychiatry Immunology of VIP: A Review and Therapeutical Perspectives
Current Pharmaceutical Design Host Background Factors Contributing to Hepatitis C Virus Clearance
Current Pharmaceutical Biotechnology Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets Bottom-Up Proteomics
Current Analytical Chemistry Metabolic Stress and Inflammation: Implication in Treatment for Neurological Disorders
CNS & Neurological Disorders - Drug Targets Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks
Current Pharmaceutical Design The Role of Nuclear Medicine in Vascular Dementia
Vascular Disease Prevention (Discontinued) Kappa Receptor Bivalent Ligands
Current Topics in Medicinal Chemistry Studies on the Pathophysiology and Genetic Basis of Migraine
Current Genomics Up-Regulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-Target Genes in Cortical Neurons by the Novel Multifunctional Iron Chelator Anti-Alzheimer Drug, M30
Current Alzheimer Research Hydrotalcites in Organic Synthesis: Multicomponent Reactions
Current Organic Synthesis Phagoptosis - Cell Death By Phagocytosis - Plays Central Roles in Physiology, Host Defense and Pathology
Current Molecular Medicine Increasing Expression of Heme Oxygenase-1 by Proteasome Inhibition Protects Astrocytes from Heme-mediated Oxidative Injury
Current Neurovascular Research Intracellular Accumulation of Toxic Turn Amyloid-β is Associated with Endoplasmic Reticulum Stress in Alzheimer’s Disease
Current Alzheimer Research Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
Current Drug Metabolism Capturing and Amplifying Impurities from Recombinant Therapeutic Proteins Via Combinatorial Peptide Libraries: A Proteomic Approach
Current Pharmaceutical Biotechnology Hypoxic Preconditioning Increases Blood-Brain Barrier Disruption in the Early Stages of Cerebral Ischemia
Current Neurovascular Research NMDA Receptors and Learning and Memory Processes
Current Drug Targets Inhibition of Early Upstream Events in Prodromal Alzheimer’s Disease by Use of Targeted Antioxidants
Current Aging Science